Managing drug-resistant epilepsy: challenges and solutions

Despite the development of new antiepileptic drugs (AEDs), ~20%–30% of people with epilepsy remain refractory to treatment and are said to have drug-resistant epilepsy (DRE). This multifaceted condition comprises intractable seizures, neurobiochemical changes, cognitive decline, and psychosocial dys...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalic, Linda, Cook, Mark J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068473/
https://www.ncbi.nlm.nih.gov/pubmed/27789949
http://dx.doi.org/10.2147/NDT.S84852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068473/
https://www.ncbi.nlm.nih.gov/pubmed/27789949
http://dx.doi.org/10.2147/NDT.S84852

Ejemplares similares